| Year |
Citation |
Score |
| 2019 |
van Veen JE, Scherzer M, Boshuizen J, Chu M, Liu A, Landman A, Green S, Trejo C, McMahon M. Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAF oncoprotein kinase. Elife. 8. PMID 31452510 DOI: 10.7554/Elife.43668 |
0.688 |
|
| 2019 |
Veen JEv, Scherzer M, Boshuizen J, Chu M, Liu A, Landman A, Green S, Trejo C, McMahon M. Author response: Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase Elife. DOI: 10.7554/Elife.43668.050 |
0.606 |
|
| 2015 |
Green S, Trejo CL, McMahon M. PIK3CAH1047R Accelerates and Enhances KRASG12D-Driven Lung Tumorigenesis. Cancer Research. 75: 5378-91. PMID 26567140 DOI: 10.1158/0008-5472.Can-15-1249 |
0.675 |
|
| 2013 |
Trejo CL, Green S, Marsh V, Collisson EA, Iezza G, Phillips WA, McMahon M. Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression. Cancer Research. 73: 6448-61. PMID 24019382 DOI: 10.1158/0008-5472.Can-13-0681 |
0.677 |
|
| 2012 |
Collisson EA, Trejo CL, Silva JM, Gu S, Korkola JE, Heiser LM, Charles RP, Rabinovich BA, Hann B, Dankort D, Spellman PT, Phillips WA, Gray JW, McMahon M. A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma. Cancer Discovery. 2: 685-93. PMID 22628411 DOI: 10.1158/2159-8290.Cd-11-0347 |
0.524 |
|
| 2012 |
Trejo CL, Juan J, Vicent S, Sweet-Cordero A, McMahon M. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E. Cancer Research. 72: 3048-59. PMID 22511580 DOI: 10.1158/0008-5472.Can-11-3649 |
0.687 |
|
| Show low-probability matches. |